Tag: Pharmaceutical Manufacturing

WuXi has Secured a Deal to Build a New Facility in Massachusetts

WuXi Biologics and the Worcester Business Development Corporation (WBDC) announced the successful signing of a land deal for WuXi Biologics’ clinical and commercial manufacturing facility (MFG11) in W...

Management Personnel Allowed to Visit Pharma Units in Baddi

Managing directors and other senior executives of pharmaceutical units located in Baddi will now be able to visit the plants as Asia’s largest pharma hub located in Himachal Pradesh looks to resume op...

Biopharma: New standard for Single Use System

ASTM International, which defines over 12,000 processing standards and operates globally, has released a new standard which the organisation says will help to prevent the contamination of biopharmaceu...

Fifty Pharma Facilities have Shuttered their Operations in Baddi (Asia’s Largest Pharma Hub)

“Major pharma units including Wockhardt, USV Pharma, Sun Pharmaceuticals are among the 50 units that shut operations on April 12,” Navneet Marwaha, state drug controller of HP told. The state deput...

A Production of a Feed Grade Vitamin E Is Starting in Lipetsk Region

MEGAMIX, the producer of protein, vitamin and mineral supplements for all types of livestock and poultry, launches a vitamin E production shop at its production site OEZ Terbuny (Lipetsk Region). T...

The President of Russia Has Signed Laws in the Sphere of Circulation of Drug Products

December 27, 2019 Vladimir Putin signed a number of federal laws in the circulation of drug products and medical devices. All documents were published on December 28 on the official Internet portal of...

GE Healthcare and Germfree to Develop Manufacturing Solution for Biotherapeutics

GE Healthcare and Germfree are joining expertise to develop a fully integrated, expandable manufacturing solution for emerging biotherapeutics, including gene therapy. The manufacturing solution wi...

Sagent’s Site FDA-Approved for Products Manufacturing

Nichi-Iko Pharmaceutical Co., Ltd. and Sagent Pharmaceuticals, Inc., a Nichi-Iko Group Company ("Sagent"), a leader of specialty pharmaceutical products with an emphasis on the injectable market, toda...

Due to Poor Manufacturing Practices U.S. Marshals Seized Life Rising Corporation’ Production

fda office
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized more than 300,000 containers of dietary supplements, including tablets, capsules, and teas from Life Rising Corporation. ...

PCI Expands its Flagship Manufacturing Centre

PCI Pharma Services (PCI) has announced further investment to expand its flagship manufacturing centre in Tredegar, Wales. The plan for the Tredegar site will double its highly potent tableting cap...

Rentschler Fill Solutions launched a fill and finish facility in Austria

pharma vial
Rentschler Fill Solutions GmbH, a contract development and manufacturing organization and expert in aseptic fill and finish services, officially inaugurated its new facility in Rankweil (Austria).

NEARMEDIC launched the first Russian facility for DNA testing reagents production

The full-cycle facility is to manufacture reactants for genetic person’s identification and establishment of filiation through DNA tests.

SID&GP presented the inspection overview of foreign pharma manufacturers

Mr. Vladislav Shestakov presented a review of the results of inspections of foreign pharmaceutical manufacturers at the PharmMedCirculation 2018 conference.

Ajinomoto Althea and OmniChem formed Ajinomoto Bio-Pharma Services

Ajinomoto Althea and OmniChem are integrating their businesses and operations as a unified CDMO, and changing their name to Ajinomoto Bio-Pharma Services.

PharmaBlock Sciences acquires a GMP manufacturing facility in China

PharmaBlock Sciences, an innovative chemistry product and service provider throughout the pharmaceutical R&D process, announced that it has acquired a GMP compliant manufacturing facility in China.

Samsung Biologics third plant commenced production

samsung biologics
Samsung BioLogics announced that its Plant 3, the world’s largest single bio manufacturing plant, has become cGMP ready and started production after its successful validation.